Bhutan vs Portugal: Access to anti-retroviral drugs, female
Bhutan
80.0%
in 2024
Portugal
82.0%
in 2017
Bhutan rank
57th
Portugal rank
56th
Access to anti-retroviral drugs, female over time
- Bhutan
- Portugal
How they compare
Portugal currently reports 82.0% against 80.0% in Bhutan, a difference of 2.0%.
Across all 18 years both countries report, Portugal has been ahead every year.
Bhutan ranks 57th and Portugal ranks 56th of 141 countries.
Portugal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.0% | 36.8% | 32.8% | Portugal |
| 2010s | 40.2% | 68.2% | 28.0% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bhutan or Portugal?
- Portugal, at 82.0% against 80.0% in Bhutan as of 2017.
- What is the difference in access to anti-retroviral drugs, female between Bhutan and Portugal?
- 2.0%, with Portugal ahead.
- How many years of comparable data are there for Bhutan and Portugal?
- 18 years are reported by both, from 2000 to 2017.
- How do Bhutan and Portugal rank globally for access to anti-retroviral drugs, female?
- Bhutan ranks 57th and Portugal ranks 56th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.